These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

308 related articles for article (PubMed ID: 38891988)

  • 1. Melanoma Management: Exploring Staging, Prognosis, and Treatment Innovations.
    Shalata W; Attal ZG; Solomon A; Shalata S; Abu Saleh O; Tourkey L; Abu Salamah F; Alatawneh I; Yakobson A
    Int J Mol Sci; 2024 May; 25(11):. PubMed ID: 38891988
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Systemic treatments for metastatic cutaneous melanoma.
    Pasquali S; Hadjinicolaou AV; Chiarion Sileni V; Rossi CR; Mocellin S
    Cochrane Database Syst Rev; 2018 Feb; 2(2):CD011123. PubMed ID: 29405038
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Latest advances in chemotherapeutic, targeted, and immune approaches in the treatment of metastatic melanoma.
    Shah DJ; Dronca RS
    Mayo Clin Proc; 2014 Apr; 89(4):504-19. PubMed ID: 24684873
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Melanoma update].
    Longvert C; Saiag P
    Rev Med Interne; 2019 Mar; 40(3):178-183. PubMed ID: 30527396
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Targeting BRAF and MEK inhibitors in melanoma in the metastatic, neoadjuvant and adjuvant setting.
    Tétu P; Baroudjian B; Lebbe C
    Curr Opin Oncol; 2020 Mar; 32(2):85-90. PubMed ID: 31895121
    [TBL] [Abstract][Full Text] [Related]  

  • 6. No longer an untreatable disease: how targeted and immunotherapies have changed the management of melanoma patients.
    Girotti MR; Saturno G; Lorigan P; Marais R
    Mol Oncol; 2014 Sep; 8(6):1140-58. PubMed ID: 25178978
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Current and future roles of targeted therapy and immunotherapy in advanced melanoma.
    Olszanski AJ
    J Manag Care Spec Pharm; 2014 Apr; 20(4):346-56. PubMed ID: 24684639
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Advances in immunotherapy for metastatic melanoma].
    Oláh J
    Magy Onkol; 2017 Jun; 61(2):132-136. PubMed ID: 28585614
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Recent Changes and Innovations in Melanoma Treatment: A Review.
    Sabag N; Yakobson A; Silberstein E
    Isr Med Assoc J; 2020 Nov; 11(22):704-710. PubMed ID: 33249792
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cutaneous Melanoma - A Review of Systemic Therapies.
    Lee KA; Nathan P
    Acta Derm Venereol; 2020 Jun; 100(11):adv00141. PubMed ID: 32346745
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Immunotherapy for malignant melanoma].
    Zaremba A; Zimmer L; Griewank KG; Ugurel S; Roesch A; Schadendorf D; Livingstone E
    Internist (Berl); 2020 Jul; 61(7):669-675. PubMed ID: 32462249
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Combination of Immunotherapy With Targeted Therapy: Theory and Practice in Metastatic Melanoma.
    Yu C; Liu X; Yang J; Zhang M; Jin H; Ma X; Shi H
    Front Immunol; 2019; 10():990. PubMed ID: 31134073
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cutaneous melanoma: a model to study cancer metastasis.
    Leong SP; Gershenwald JE; Soong SJ; Schadendorf D; Tarhini AA; Agarwala S; Hauschild A; Soon CW; Daud A; Kashani-Sabet M
    J Surg Oncol; 2011 May; 103(6):538-49. PubMed ID: 21480247
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immune consequences of kinase inhibitors in development, undergoing clinical trials and in current use in melanoma treatment.
    Vella LJ; Andrews MC; Behren A; Cebon J; Woods K
    Expert Rev Clin Immunol; 2014 Aug; 10(8):1107-23. PubMed ID: 24939732
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adjuvant and Neoadjuvant Therapies in Cutaneous Melanoma.
    Ponto J; Bell RB
    Oral Maxillofac Surg Clin North Am; 2022 May; 34(2):315-324. PubMed ID: 35491081
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adjuvant immunotherapy for melanoma.
    Thomas D; Bello DM
    J Surg Oncol; 2021 Mar; 123(3):789-797. PubMed ID: 33595889
    [TBL] [Abstract][Full Text] [Related]  

  • 17. SEOM clinical guideline for the management of cutaneous melanoma (2020).
    Majem M; Manzano JL; Marquez-Rodas I; Mujika K; Muñoz-Couselo E; Pérez-Ruiz E; de la Cruz-Merino L; Espinosa E; Gonzalez-Cao M; Berrocal A
    Clin Transl Oncol; 2021 May; 23(5):948-960. PubMed ID: 33651321
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Update on systemic therapy for advanced cutaneous melanoma and recent development of novel drugs.
    Swe T; Kim KB
    Clin Exp Metastasis; 2018 Aug; 35(5-6):503-520. PubMed ID: 30019239
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Novel Targets in Melanoma: Intralesional and Combination Therapy to Manipulate the Immune Response.
    Gingrich AA; Kirane AR
    Surg Oncol Clin N Am; 2020 Jul; 29(3):467-483. PubMed ID: 32482321
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunotherapy in the Treatment of Metastatic Melanoma: Current Knowledge and Future Directions.
    Ralli M; Botticelli A; Visconti IC; Angeletti D; Fiore M; Marchetti P; Lambiase A; de Vincentiis M; Greco A
    J Immunol Res; 2020; 2020():9235638. PubMed ID: 32671117
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.